Related Articles
Ibrutinib in CLL/SLL: From bench to bedside (Review)
Challenges associated with the use of Bruton's tyrosine kinase inhibitors: A life‑saving therapy for chronic lymphocytic leukemia (Review)
Bruton's agammaglobulinemia tyrosine kinase (Btk) regulates TPA‑induced breast cancer cell invasion via PLCγ2/PKCβ/NF‑κB/AP‑1‑dependent matrix metalloproteinase‑9 activation
Bruton's tyrosine kinase inhibitor restrains Wnt signaling in chronic lymphocytic leukemia
PDGFD induces ibrutinib resistance of diffuse large B‑cell lymphoma through activation of EGFR